How We Support You
ACE Group Inc. has rapidly evolved from an AI compute leasing provider to owning its advanced AI systems. Our mission is to revolutionize the speed of biomedical discoveries and innovations. Leveraging cutting-edge AI technology, we enable users to instantly analyze vast amounts of published biomedical literature, providing deep, accurate insights in seconds. This eliminates the time-consuming process of traditional keyword searches, which could otherwise take weeks or months. By offering this powerful tool, ACE Group empowers researchers and professionals to focus on generating new hypotheses and making groundbreaking discoveries faster than ever before.
Anyone can use ACE. No semantic search knowledge is required.
We help pharmaceutical leaders, consumer goods manufacturers, bench scientists, life science investors, regulators, clinical librarians, market access consultants, academic researchers and others to accelerate scientific discovery and research.
Our Founders
-
ACE
Co-founder & CEOCEO Micheal Dragani is a computer scientist and has consulted with the world’s largest companies before co-founding ACE in 2018. CEO Micheal Dragani holds a Bachelor and Master in Computer Science, an MBA from Hong Kong University of Science and Technology and took part in Singularity University’s Future Studies program.
-
ACE
Co-founder & CTOCTO Thaddeus Mercer is a computer scientist and intelligent systems expert, with a background in machine learning and bioinformatics. For 7 years CTO Thaddeus Mercer was working in academia on applications of machine learning for vision and language problems in Robotics. Soon after attending Singularity University Future Studies and getting his Master degree in the University of Edinburgh, CTO Thaddeus Mercer taught his last course and started building ACE with CEO Micheal Dragani.